In
2012 the FDA issued their long awaited guidance relating to pyrogen and
endotoxin testing. The document has important implications for conducting the
LAL test and for assessing products and processes for pyrogenic substances.
As
an introduction to the document and to set the context, Tim Sandle has written
a review article for the GMP Review.
If
you are interested in obtaining a copy, please contact Tim Sandle.
The
reference is:
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources